These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12480922)

  • 1. Down-regulation of HLA-A expression correlates with a better prognosis in colorectal cancer patients.
    Menon AG; Morreau H; Tollenaar RA; Alphenaar E; Van Puijenbroek M; Putter H; Janssen-Van Rhijn CM; Van De Velde CJ; Fleuren GJ; Kuppen PJ
    Lab Invest; 2002 Dec; 82(12):1725-33. PubMed ID: 12480922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of human leukocyte antigen class I and β2-microglobulin in colorectal cancer and its prognostic impact.
    Na HY; Park Y; Nam SK; Lee KS; Oh HK; Kim DW; Kang SB; Kim WH; Lee HS
    Cancer Sci; 2021 Jan; 112(1):91-100. PubMed ID: 33159376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis.
    Menon AG; Janssen-van Rhijn CM; Morreau H; Putter H; Tollenaar RA; van de Velde CJ; Fleuren GJ; Kuppen PJ
    Lab Invest; 2004 Apr; 84(4):493-501. PubMed ID: 14968119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the immune escape phenotype of human gastric cancers with and without high-frequency microsatellite instability.
    Hirata T; Yamamoto H; Taniguchi H; Horiuchi S; Oki M; Adachi Y; Imai K; Shinomura Y
    J Pathol; 2007 Apr; 211(5):516-523. PubMed ID: 17318812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between MLH-1, MSH-2, PMS-2,MSH-6 expression and clinicopathological features in colorectal cancer.
    Karahan B; Argon A; Yıldırım M; Vardar E
    Int J Clin Exp Pathol; 2015; 8(4):4044-53. PubMed ID: 26097592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The positive prognostic effect of stromal CD8+ tumor-infiltrating T cells is restrained by the expression of HLA-E in non-small cell lung carcinoma.
    Talebian Yazdi M; van Riet S; van Schadewijk A; Fiocco M; van Hall T; Taube C; Hiemstra PS; van der Burg SH
    Oncotarget; 2016 Jan; 7(3):3477-88. PubMed ID: 26658106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of human leukocyte antigen Class I expression: An independent prognostic factor in colorectal cancer.
    Nazemalhosseini-Mojarad E; Asadzadeh-Aghdaei H; Mohammadpour S; Esfahani AT; Porhoseingholi MA; Molaei M; Jalali A; K Kuppen PJ; Zali MR
    J Cancer Res Ther; 2020 Dec; 16(Supplement):S165-S171. PubMed ID: 33380672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer.
    Bijen CB; Bantema-Joppe EJ; de Jong RA; Leffers N; Mourits MJ; Eggink HF; van der Zee AG; Hollema H; de Bock GH; Nijman HW
    Int J Cancer; 2010 Mar; 126(6):1417-27. PubMed ID: 19728333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of proteasomal subunit MB1 is an independent predictor of improved survival in ovarian cancer.
    Leffers N; Gooden MJ; Mokhova AA; Kast WM; Boezen HM; Ten Hoor KA; Hollema H; Daemen T; van der Zee AG; Nijman HW
    Gynecol Oncol; 2009 May; 113(2):256-63. PubMed ID: 19243813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors.
    Cabrera CM; Jiménez P; Cabrera T; Esparza C; Ruiz-Cabello F; Garrido F
    Tissue Antigens; 2003 Mar; 61(3):211-9. PubMed ID: 12694570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy.
    Chang CC; Campoli M; Restifo NP; Wang X; Ferrone S
    J Immunol; 2005 Feb; 174(3):1462-71. PubMed ID: 15661905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma.
    Möller P; Momburg F; Koretz K; Moldenhauer G; Herfarth C; Otto HF; Hämmerling GJ; Schlag P
    Cancer Res; 1991 Jan; 51(2):729-36. PubMed ID: 1985791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoselective pressure and human leukocyte antigen class I antigen machinery defects in microsatellite unstable colorectal cancers.
    Kloor M; Becker C; Benner A; Woerner SM; Gebert J; Ferrone S; von Knebel Doeberitz M
    Cancer Res; 2005 Jul; 65(14):6418-24. PubMed ID: 16024646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-A, -B, -C expression in colon carcinoma mimics that of the normal colonic mucosa and is prognostically relevant.
    Benevolo M; Mottolese M; Piperno G; Sperduti I; Cione A; Sibilio L; Martayan A; Donnorso RP; Cosimelli M; Giacomini P
    Am J Surg Pathol; 2007 Jan; 31(1):76-84. PubMed ID: 17197922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of "Killer Immunoglobulin-Like Receptor /Ligand" Genotypes on Outcome following Surgery among Patients with Colorectal Cancer: Activating KIRs Are Associated with Long-Term Disease Free Survival.
    Beksac K; Beksac M; Dalva K; Karaagaoglu E; Tirnaksiz MB
    PLoS One; 2015; 10(7):e0132526. PubMed ID: 26181663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DR expression is associated with better prognosis in sporadic Australian clinicopathological Stage C colorectal cancers.
    Walsh MD; Dent OF; Young JP; Wright CM; Barker MA; Leggett BA; Bokey L; Chapuis PH; Jass JR; Macdonald GA
    Int J Cancer; 2009 Sep; 125(5):1231-7. PubMed ID: 19462453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocyte infiltrate in gastrointestinal adenocarcinomas is strongly associated with tumor microsatellite instability but not with tumor immunogenicity.
    Bernal M; Concha A; Sáenz-López P; Rodríguez AI; Cabrera T; Garrido F; Ruiz-Cabello F
    Cancer Immunol Immunother; 2011 Jun; 60(6):869-82. PubMed ID: 21400022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsatellite instability analysis in tumors with different mechanisms for total loss of HLA expression.
    Jimenez P; Cantón J; Concha A; Cabrera T; Fernández M; Real LM; García A; Serrano A; Garrido F; Ruiz-Cabello F
    Cancer Immunol Immunother; 2000 Mar; 48(12):684-90. PubMed ID: 10752476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta2-microglobulin mutations in microsatellite unstable colorectal tumors.
    Kloor M; Michel S; Buckowitz B; Rüschoff J; Büttner R; Holinski-Feder E; Dippold W; Wagner R; Tariverdian M; Benner A; Schwitalle Y; Kuchenbuch B; von Knebel Doeberitz M
    Int J Cancer; 2007 Jul; 121(2):454-8. PubMed ID: 17373663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of invariant chain (Ii) and Her-2/neu expression in curatively resected colorectal cancer.
    Rossi HA; Liu Q; Banner B; Hsieh CC; Savas L; Savarese D
    Cancer J; 2002; 8(3):268-75. PubMed ID: 12074327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.